Predictive Factors of Mortality in Pediatric Pleuropulmonary Blastoma: A Surveillance Epidemiology and End Results Database Analysis
- PMID: 38912026
- PMCID: PMC11192257
- DOI: 10.4103/jiaps.jiaps_235_23
Predictive Factors of Mortality in Pediatric Pleuropulmonary Blastoma: A Surveillance Epidemiology and End Results Database Analysis
Abstract
Purpose: Pleuropulmonary blastoma (PPB) is a rare malignancy associated with mutations in the DICER1 gene. Early-stage disease (PPB type I) mimics cystic lung malformations and develops in infants <1 year of age, and PPB type II and III arises in older children. The objective of this study was to analyze predictive factors of mortality in pediatric patients aged 0-19 years diagnosed with PPB between 2000 and 2019 in the USA.
Methods: A retrospective analysis of pediatric patients (0-19 years) in the Surveillance Epidemiology and End Results database was conducted from 2000 to 2019 with a diagnosis of PPB using International Classification of Disease for Oncology, third edition code 8973/3 and rare tumor code 45. Demographics, incidence, staging, treatment, and mortality were extracted. A mortality risk predictive equation was developed using logistic regression. Statistical analysis was conducted through Microsoft Excel Analysis ToolPak and Solver.
Results: There were a total of 71 new cases of PPB during the study period, with 16 (22%) deaths. The demographic analysis demonstrated that 40/71 (56.3%) patients were female, 57/71 (80.3%) were White, and 64/71 (90.1%) resided in metropolitan areas. Regression analysis demonstrated a statistically significant correlation between mortality and stage (P = 0.029), need for chemotherapy (P = 0.047), and female sex (P = 0.019). There was no significant correlation between mortality and need for radiation, race, or age at diagnosis. Multiple logistic regression analysis generated a predictive equation of mortality dependent on the stage of PPB, need for chemotherapy, and sex. This equation has an 82% accuracy, 81% sensitivity, and an 18% false positive rate.
Conclusion: PPB is a rare disease. Distinguishing PPB from benign cystic lung malformations in infancy is important to avoid progression to Type II and III PPB. Advanced stages of PPB have a greater need for systemic chemotherapy and radiation with a poor prognosis.
Keywords: DICER 1; pleuropulmonary blastoma; prognosis.
Copyright: © 2024 Journal of Indian Association of Pediatric Surgeons.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Mlika M, Anjum F, El Mezni F. StatPearls. Treasure Island, FL, USA: StatPearls Publishing; 2022. [[Last accessed on 2022 Sep 18]]. Pleuropulmonary blastoma. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534211/ - PubMed
-
- Sáez B J, Pattillo S JC, Vuletin S JF. Pleuro-pulmonary blastoma presenting as a chest wall deformity: A case report. Rev Chil Pediatr. 2018;89:231–5. - PubMed
-
- Priest JR, Hill DA, Williams GM, Moertel CL, Messinger Y, Finkelstein MJ, et al. Type I pleuropulmonary blastoma: A report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol. 2006;24:4492–8. - PubMed
LinkOut - more resources
Full Text Sources